Senior insider sale
Chief Medical Officer at BELITE BIO, INC — senior position signals high conviction
$2.93M
20K shares
What this filing means
SCHOLL HENDRIK PETER plans to sell 20K shares of BELITE BIO, INC valued at approximately $2.93M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/18/2026ACC: 0001968582-26-000631
Officer· Chief Medical Officer
Since Mar 2026
20K
Shares to sell
$2.93M
Approx. market value
10K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months2
Vested RSUs
Compensation
11/3/2025
7.50KVested RSUs
Compensation
10/17/2025
2.50KTotal acquired10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/3/2025 | Vested RSUs Compensation | 7.50K | — |
10/17/2025 | Vested RSUs Compensation | 2.50K | — |
| Total | 10K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
10K
Market value
$1.44M
6/16/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
10K
Market value
$1.48M
6/18/2026
Total
Units
20K
Value
$2.93M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/16/2026 | 10K | $1.44M | — | Completed |
| Planned — Approximate Date | ||||
6/18/2026 | 10K | $1.48M | NASDAQ | Planned |
| Total | 20K | $2.93M | ||